Xvivo Perfusion AB (XVIPF)
29.39
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Xvivo Perfusion EPS Diluted (Quarterly) : 0.1258 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Getinge AB | 0.1611 |
| Paxman AB | -0.0006 |
| Enovis Corp. | -0.1529 |
| Edwards Lifesciences Corp. | 0.6556 |
| IDEXX Laboratories, Inc. | 3.474 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.971M |
| Revenue (Quarterly) | 26.36M |
| Total Expenses (Quarterly) | 22.39M |
| Enterprise Value | 906.30M |
| Gross Profit Margin (Quarterly) | 63.69% |
| Profit Margin (Quarterly) | 15.06% |
| Earnings Yield | 0.86% |
| Operating Earnings Yield | 1.07% |
| Normalized Earnings Yield | 0.853 |